2025 Winter Clinical™ Miami Highlights
Our Annual Winter Clinical™ Miami conference is framed to improve our attendees' value and clinical skills through a uniquely designed educational experience. Check back here as we highlight key sessions and posters during the conference!
Friday, January 17, 2025
Check Out Highlights From WCM25 Below
Contact Dermatitis Update for 2025
Kicking off the first day of lectures in Miami, David Cohen, MD, MPH, provided an insightful overview of contact dermatitis, focusing on allergens dermatologists should monitor in 2025....
Read more
What's New in the Treatment of Non-Scarring Alopecia
In this presentation, Amy McMichael MD, discussed the latest updates in the treatment of common types of non-scarring alopecia, including pattern hair loss and alopecia areata (AA). She...
Read more
Topical & Systemic Antibiotic Therapy
Antimicrobial resistance (AMR) has become one of the most urgent global health crises, as highlighted by Theodore Rosen, MD, in his impactful session, "Topical and Systemic Antibiotic Therapy."...
Read more
What's New Pediatric Infections
Rounding out the first day, Elizabeth Swanson, MD, presented an engaging review of emerging trends and treatments in pediatric infections, offering updates across various dermatologic conditions. She began...
Read more
Expert Consensus-Based Recommendations on the Use of Photodynamic Therapy in Actinic Keratosis Patients
Authors: Vishal A. Patel, MD; Sarah T. Arron, MD, Brian Berman, MD, PhD; M. Shane Chapman, MD, MBA; Anokhi Jambusaria-Pahlajani, MD; George Martin, MD; Anthony M. Rossi, MD;...
Read more
Pilot Study Utilizing Short Contact Protocols For Treatment Of Actinic Keratoses (AK) With ALA Gel-Red Light Photodynamic Therapy (PDT).
Saturday, January 18, 2025
Therapeutic Update
Gary Goldenberg, MD, opened day 2 with an extensive review of the latest research on a broad range of dermatologic conditions, including acne vulgaris, psoriasis, atopic dermatitis (AD),...
Read more
Psoriasis Tips
Mark Lebwohl, MD, addressed a common clinical dilemma: selecting appropriate treatment regimens for patients with psoriasis amidst an expanding array of biologics and small-molecule inhibitors. His presentation emphasized...
Read more
Say ‘No’ to Spontaneity: Treating Chronic Spontaneous Urticaria
Chronic spontaneous urticaria (CSU) is defined by recurring hives, swelling, or both, and lasting 6 weeks or more, without identifiable triggers such as allergies or external stimuli. Dawn...
Read more
Gene Expression Profiling of Skin Cancer: Transforming Diagnosis and Prognosis
Gene expression profiling (GEP) is revolutionizing the management of skin cancers by enhancing diagnostic precision and prognostic accuracy. Darrell Rigel, MD, MS, and Aaron Farberg, MD, emphasized the...
Read more
Clinical Pearls Panel
Rounding out the second day was a multispeaker session on clinical pearls by Gary Goldenberg, MD, Brad Glick, DO, Edward (Ted) Lain, MD, MBA, Elizabeth (Lisa) Swanson, MD,...
Read more
Sunday, January 19, 2025
Botulinum Toxin Update
Mark Nestor, MD, PhD, provided an in-depth update on the science of botulinum toxin type A (BoNT-A), focusing on how to select the right toxin and optimize clinical...
Read more
Choosing the Right Systemic Treatment for Your Patients with Atopic Dermatitis
While many systemic treatments are available for atopic dermatitis (AD), Dr Alexandra Golant focused her lecture on the latest advancements and evidence-based strategies for choosing the right therapy....
Read more
Alopecia Areata Update
Alopecia areata is a complex autoimmune condition with profound physical and emotional impacts on patients. Natasha Mesinkovska, MD, PhD, opened her presentation with a fascinating discussion on mortality...
Read more
Worldwide Clinical and Real-World Exposure to Baricitinib
Authors: Ruth Ann Vleugels, Brittany Craiglow, Arash Mostaghimi, Elise Olsen, Angelina Sontag, Karen Denning, Najwa Somani, Maria Hordinsky
Baricitinib, an oral JAK inhibitor, is approved for conditions such...
Read more
Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study
Monday, January 20, 2025
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 1
Darrell S. Rigel, MD, MS started this multi-part discussion highlighting significant advancements in dermatologic oncology. Key updates include the efficacy of tirbanibulin 1% for treating actinic keratosis (AK)...
Read more
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 2
In Part 2 of “What Did Dermatology Bring to the Table in 2024 that Impact Patient Care in 2025” series, Seemal Desai, MD, Mark Lebwohl, MD, Dawn Merritt,...
Read more
What Did Dermatology Bring to the Table in 2024 That Impacts Patient Care in 2025 - Part 3
In this presentation, Gary Goldenberg, MD and Mark Nestor, MD, PhD, provided valuable insights into botulinum toxin (Botox) injections, collagen biostimulators, androgenetic alopecia (AGA) treatments, and innovative aesthetic...
Read more
Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe Atopic Dermatitis: Results Up to 3 Years From Adjoin
Authors: Emma Guttman-Yassky, Alan Irvine, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Lynda Spelman, Jonathan Silverberg, Heidi Crane, Hany Elmaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Evangeline...
Read more





